Clinical trials
Observational Genital Diseases, Female trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 9 |
| Unknown status | 7 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Derince Training and Research Hospital | 3 |
| Acibadem University | 2 |
| Intuitive Surgical | 2 |
| Ain Shams University | 1 |
| Azienda Ospedaliera San Giovanni Battista | 1 |
| Bagcilar Training and Research Hospital | 1 |
| Batman Training and Research Hospital | 1 |
| Central Hospital, Nancy, France | 1 |
| Chinese University of Hong Kong | 1 |
| Fondation Hôpital Saint-Joseph | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genital Diseases, Female | 38 |
| Ovarian Neoplasms | 5 |
| Endometriosis | 3 |
| Uterine Cervical Neoplasms | 3 |
| Endometrial Neoplasms | 2 |
| Genital Diseases, Male | 2 |
| Infertility | 2 |
| Infertility, Female | 2 |
| Inflammation | 2 |
| Neoplasms | 2 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.